JP2015521202A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015521202A5 JP2015521202A5 JP2015515176A JP2015515176A JP2015521202A5 JP 2015521202 A5 JP2015521202 A5 JP 2015521202A5 JP 2015515176 A JP2015515176 A JP 2015515176A JP 2015515176 A JP2015515176 A JP 2015515176A JP 2015521202 A5 JP2015521202 A5 JP 2015521202A5
- Authority
- JP
- Japan
- Prior art keywords
- ica
- positive
- pnag
- pga
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261653389P | 2012-05-30 | 2012-05-30 | |
| US61/653,389 | 2012-05-30 | ||
| US201361827661P | 2013-05-26 | 2013-05-26 | |
| US61/827,661 | 2013-05-26 | ||
| PCT/US2013/043283 WO2013181348A1 (en) | 2012-05-30 | 2013-05-30 | Polysaccharide compositions and methods of use |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017186345A Division JP6663402B2 (ja) | 2012-05-30 | 2017-09-27 | 多糖組成物およびその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015521202A JP2015521202A (ja) | 2015-07-27 |
| JP2015521202A5 true JP2015521202A5 (enExample) | 2016-07-21 |
| JP6403667B2 JP6403667B2 (ja) | 2018-10-10 |
Family
ID=49673891
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015515176A Active JP6403667B2 (ja) | 2012-05-30 | 2013-05-30 | 多糖組成物およびその使用 |
| JP2017186345A Active JP6663402B2 (ja) | 2012-05-30 | 2017-09-27 | 多糖組成物およびその使用 |
| JP2018229987A Pending JP2019059763A (ja) | 2012-05-30 | 2018-12-07 | 多糖組成物およびその使用 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017186345A Active JP6663402B2 (ja) | 2012-05-30 | 2017-09-27 | 多糖組成物およびその使用 |
| JP2018229987A Pending JP2019059763A (ja) | 2012-05-30 | 2018-12-07 | 多糖組成物およびその使用 |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US20150165016A1 (enExample) |
| EP (1) | EP2854822B1 (enExample) |
| JP (3) | JP6403667B2 (enExample) |
| KR (1) | KR102282726B1 (enExample) |
| CN (2) | CN104602696A (enExample) |
| AU (4) | AU2013267444A1 (enExample) |
| BR (1) | BR112014030025A2 (enExample) |
| CA (2) | CA2879592C (enExample) |
| CL (1) | CL2014003276A1 (enExample) |
| DK (1) | DK2854822T3 (enExample) |
| ES (1) | ES2826000T3 (enExample) |
| HK (1) | HK1209031A1 (enExample) |
| IL (1) | IL235968B (enExample) |
| MX (2) | MX2014014649A (enExample) |
| NZ (1) | NZ703260A (enExample) |
| PH (1) | PH12014502680A1 (enExample) |
| RU (2) | RU2019101166A (enExample) |
| SG (3) | SG10201911609XA (enExample) |
| WO (1) | WO2013181348A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL229487B1 (pl) * | 2002-11-12 | 2018-07-31 | Brigham & Womens Hospital Inc | Kompozycja zawierająca polimer β-1,6-glukozaminy, kompozycja zawierająca przeciwciało, kompozycja farmaceutyczna, sposób wytwarzania wyodrębnionego polisacharydu, sposób identyfikacji obecności deacetylowanej poli-N-acetyloglukozaminy (dPNAG) i/ lub poli-N-acetyloglukozaminy (PNAG), wyodrębniony polisacharyd do zastosowania w leczeniu lub profilaktyce zakażenia, wyodrębniony polisacharyd do zastosowania do wytwarzania przeciwciał, w tym przeciwciał monoklonalnych, wyodrębniony polisacharyd do zastosowania w identyfikacji przeciwciała monoklonalnego |
| ES2415358T3 (es) | 2004-04-21 | 2013-07-25 | The Brigham And Women's Hospital, Inc. | Péptidos de fijación a la poli-N-acetil glucosamina (PNAG/DPNAG) y procedimientos para el uso de los mismos |
| CN102159540B (zh) | 2008-07-21 | 2015-08-12 | 布赖汉姆妇女医院 | 与合成的β-1,6葡糖胺寡糖相关的方法和组合物 |
| WO2016069888A1 (en) | 2014-10-29 | 2016-05-06 | University Of Wyoming | Compositions and methods for making and using hydrolytic enzymes for degrading polysaccharides made by foodborne pathogenic bacteria |
| BR112019003992A2 (pt) | 2016-09-02 | 2019-05-28 | Sanofi Pasteur Inc | vacina contra neisseria meningitidis |
| WO2019226920A1 (en) * | 2018-05-23 | 2019-11-28 | Meharry Medical College | Molecules derived from gram-positive bacteria |
| US12397014B2 (en) | 2019-02-05 | 2025-08-26 | The Brigham And Women's Hospital, Inc. | Polysaccharide compositions for use in treating filariasis |
| CN110638830A (zh) * | 2019-09-29 | 2020-01-03 | 深圳市生命谷生命科技研究院 | 消化泥鳅多糖调节免疫功能或治疗免疫相关疾病的用途 |
| US11173199B2 (en) | 2019-11-13 | 2021-11-16 | Alopexx Inc. | Low contaminant compositions |
| JP2023502276A (ja) * | 2019-11-22 | 2023-01-23 | アロペックス・インコーポレイテッド | Ｐｎａｇを含む微生物に対する持続的治療を提供するための方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2046920B1 (enExample) | 1969-06-19 | 1974-05-03 | Citizen Watch Co Ltd | |
| US3940475A (en) | 1970-06-11 | 1976-02-24 | Biological Developments, Inc. | Radioimmune method of assaying quantitatively for a hapten |
| US4737456A (en) | 1985-05-09 | 1988-04-12 | Syntex (U.S.A.) Inc. | Reducing interference in ligand-receptor binding assays |
| US5567610A (en) | 1986-09-04 | 1996-10-22 | Bioinvent International Ab | Method of producing human monoclonal antibodies and kit therefor |
| US5565354A (en) | 1986-09-05 | 1996-10-15 | Sandoz Ltd. | Production of human monoclonal antibodies specific for hepatitis B surface antigen |
| US5534615A (en) | 1994-04-25 | 1996-07-09 | Genentech, Inc. | Cardiac hypertrophy factor and uses therefor |
| DE60039450D1 (de) * | 1999-12-02 | 2008-08-21 | Novartis Vaccines & Diagnostic | Zusammensetzungen und methoden zur stabilisierung von biologischen molekülen nach lyophilisierung |
| PL229487B1 (pl) * | 2002-11-12 | 2018-07-31 | Brigham & Womens Hospital Inc | Kompozycja zawierająca polimer β-1,6-glukozaminy, kompozycja zawierająca przeciwciało, kompozycja farmaceutyczna, sposób wytwarzania wyodrębnionego polisacharydu, sposób identyfikacji obecności deacetylowanej poli-N-acetyloglukozaminy (dPNAG) i/ lub poli-N-acetyloglukozaminy (PNAG), wyodrębniony polisacharyd do zastosowania w leczeniu lub profilaktyce zakażenia, wyodrębniony polisacharyd do zastosowania do wytwarzania przeciwciał, w tym przeciwciał monoklonalnych, wyodrębniony polisacharyd do zastosowania w identyfikacji przeciwciała monoklonalnego |
| ES2415358T3 (es) * | 2004-04-21 | 2013-07-25 | The Brigham And Women's Hospital, Inc. | Péptidos de fijación a la poli-N-acetil glucosamina (PNAG/DPNAG) y procedimientos para el uso de los mismos |
| CN102159540B (zh) | 2008-07-21 | 2015-08-12 | 布赖汉姆妇女医院 | 与合成的β-1,6葡糖胺寡糖相关的方法和组合物 |
| US12397014B2 (en) * | 2019-02-05 | 2025-08-26 | The Brigham And Women's Hospital, Inc. | Polysaccharide compositions for use in treating filariasis |
-
2013
- 2013-05-30 RU RU2019101166A patent/RU2019101166A/ru unknown
- 2013-05-30 KR KR1020147036646A patent/KR102282726B1/ko not_active Expired - Fee Related
- 2013-05-30 US US14/404,303 patent/US20150165016A1/en not_active Abandoned
- 2013-05-30 SG SG10201911609XA patent/SG10201911609XA/en unknown
- 2013-05-30 CA CA2879592A patent/CA2879592C/en active Active
- 2013-05-30 JP JP2015515176A patent/JP6403667B2/ja active Active
- 2013-05-30 BR BR112014030025A patent/BR112014030025A2/pt not_active IP Right Cessation
- 2013-05-30 ES ES13798089T patent/ES2826000T3/es active Active
- 2013-05-30 EP EP13798089.2A patent/EP2854822B1/en active Active
- 2013-05-30 HK HK15109685.4A patent/HK1209031A1/xx unknown
- 2013-05-30 RU RU2014152261A patent/RU2014152261A/ru not_active Application Discontinuation
- 2013-05-30 CN CN201380040356.1A patent/CN104602696A/zh active Pending
- 2013-05-30 CA CA3241764A patent/CA3241764A1/en active Pending
- 2013-05-30 SG SG11201500428XA patent/SG11201500428XA/en unknown
- 2013-05-30 NZ NZ703260A patent/NZ703260A/en not_active IP Right Cessation
- 2013-05-30 MX MX2014014649A patent/MX2014014649A/es unknown
- 2013-05-30 WO PCT/US2013/043283 patent/WO2013181348A1/en not_active Ceased
- 2013-05-30 SG SG10201609902YA patent/SG10201609902YA/en unknown
- 2013-05-30 DK DK13798089.2T patent/DK2854822T3/da active
- 2013-05-30 CN CN201910419108.7A patent/CN110464839A/zh active Pending
- 2013-05-30 AU AU2013267444A patent/AU2013267444A1/en not_active Abandoned
-
2014
- 2014-11-27 IL IL235968A patent/IL235968B/en active IP Right Grant
- 2014-11-28 MX MX2019006620A patent/MX2019006620A/es unknown
- 2014-11-28 CL CL2014003276A patent/CL2014003276A1/es unknown
- 2014-12-01 PH PH12014502680A patent/PH12014502680A1/en unknown
-
2017
- 2017-09-27 JP JP2017186345A patent/JP6663402B2/ja active Active
-
2018
- 2018-03-14 AU AU2018201798A patent/AU2018201798A1/en not_active Abandoned
- 2018-12-07 JP JP2018229987A patent/JP2019059763A/ja active Pending
-
2020
- 2020-02-07 AU AU2020200908A patent/AU2020200908A1/en not_active Abandoned
-
2022
- 2022-03-02 AU AU2022201447A patent/AU2022201447B2/en active Active
-
2023
- 2023-12-01 US US18/526,557 patent/US20240358811A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015521202A5 (enExample) | ||
| RU2014152261A (ru) | Композиции полисахаридов и способы применения | |
| Abdolmohammadi Khiav et al. | Vaccination against pathogenic clostridia in animals: A review | |
| Morais et al. | Next-generation whole-cell pneumococcal vaccine | |
| Rossi et al. | Protective effect of oral administration of transgenic tobacco seeds against verocytotoxic Escherichia coli strain in piglets | |
| Kang et al. | In vivo induction of mucosal immune responses by intranasal administration of chitosan microspheres containing Bordetella bronchiseptica DNT | |
| JP2006513166A5 (enExample) | ||
| Zhang et al. | A combined Clostridium perfringens/Trueperella pyogenes inactivated vaccine induces complete immunoprotection in a mouse model | |
| Orth et al. | Prevention and treatment of enterohemorrhagic Escherichia coli infections in humans | |
| Alabdullah et al. | Evaluation of the efficacy of a cholera toxin-based staphylococcus aureus vaccine against bovine intramammary challenge | |
| García-García et al. | Pathogenesis and immunomodulation of urinary tract infections caused by uropathogenic Escherichia coli | |
| JP2018511303A5 (enExample) | ||
| Xu et al. | Effects of enterotoxigenic Escherichia coli challenge on jejunal morphology and microbial community profiles in weaned crossbred piglets | |
| Girard et al. | Use of virulence factor-specific egg yolk-derived immunoglobulins as a promising alternative to antibiotics for prevention of attaching and effacing Escherichia coli infections | |
| Pors et al. | Outer membrane vesicles of Gallibacterium anatis induce protective immunity in egg-laying hens | |
| Rossi et al. | Tobacco seed-based oral vaccination against verocytotoxic O138 Escherichia coli as alternative approach to antibiotics in weaned piglets | |
| Awad et al. | The sialidase NanS enhances non-TcsL mediated cytotoxicity of Clostridium sordellii | |
| Pan et al. | Oral delivery of novel recombinant lactobacillus elicit high protection against staphylococcus aureus pulmonary and skin infections | |
| FARAHMAND et al. | Identification of Toxic Shock Syndrome Toxin-1 (TSST-1) gene in Staphylococcus aureus isolated from bovine mastitis milk | |
| US20110129479A1 (en) | Immunogen selection directed in immunoglobulin packages in plasma and colostrum and method of making and using same | |
| Samanta | Veterinary bacteriology | |
| Hosseini et al. | Immunogenicity of the nanovaccine containing intimin recombinant protein in the BALB/c mice | |
| Townsend et al. | The neonatal intestinal microbial flora, immunity, and infections | |
| CN101002947B (zh) | 一种用于细菌病治疗的靶向药物及其制备方法 | |
| Aves et al. | A virus-like particle-based F4 enterotoxigenic Escherichia coli vaccine is inhibited by maternally derived antibodies in piglets but generates robust responses in sows |